• Skip to content
  • Skip to search

  • Behind the Science magazine
  • Company
    • Company
    • Purpose, strategy and culture
    • GSK at a glance
    • History and heritage
    • Board of Directors and Executive Committee
    • Board information
    • Governance
      • Governance
      • Committees
      • Shareholders
      • Sarbanes-Oxley Act 2002
      • Compliance
    • Policy positions
    • Codes, standards and reports
  • Innovation
    • Innovation
    • Our leading scientists
      • Our leading scientists
      • Dr Tony Wood
      • Dr Sabine Luik
      • Dr Hesham Ahmed Abdullah
      • Dr Kaivan Khavandi
      • Dr Christopher Austin
      • Charlotte Allerton
      • Dr Sanjay Gurunathan
    • Research and development approach
    • Pipeline
    • Therapeutic areas
      • Therapeutic areas
      • Respiratory, immunology and inflammation
      • Oncology
      • HIV
      • Infectious diseases
    • Tech
      • Tech
      • Post-quantum cryptography
    • Clinical trials at GSK
      • Clinical trials at GSK
      • Provision of unapproved medicines for unmet medical needs
      • Data transparency
      • Representative clinical studies
    • Partnering with GSK
      • Partnering with GSK
      • Supported studies
    • R&D locations
      • R&D locations
      • Flagship R&D centre in Cambridge, UK
  • Products
    • Products
    • Product areas
    • Products A-Z
  • Responsibility
    • Responsibility
    • Access
    • Global health and health security
      • Global health and health security
      • Global health
      • Health security
      • Using our science for global health
      • Africa Open Lab
    • Environment
      • Environment
      • Climate
      • Freshwater
      • Land
      • Oceans
      • Materials and waste
      • Health system sustainability
    • Inclusion
    • Ethical standards
      • Ethical standards
      • Working with third parties
      • Public policy and patient advocacy
      • Human rights
      • Use of animals
      • Engaging with healthcare professionals
    • Product governance
    • Grants and donations
    • Charitable investments
    • Responsibility reports
      • Responsibility reports
      • Reports archive
  • Investors
    • Investors
    • Why invest in GSK?
    • Quarterly results
    • Financial reports
      • Financial reports
      • Annual Report 2025
      • Corporate reports archive
    • Responsible business
    • Speeches and presentations
    • Science publications
    • Events calendar
    • Dividend and share price
      • Dividend and share price
      • GSK share price
      • Share price calculators (GBp/USD)
      • Dividend calculators (GBp/USD)
      • Dividend calendar
    • Analyst consensus
    • Stock exchange announcements
      • Stock exchange announcements
      • London (RNS)
      • London (RNS) inside information
      • New York (SEC)
      • Sign up for announcements
    • Shareholder information
      • Shareholder information
      • Manage your shares
      • Annual General Meeting
      • General Meeting
      • Annual Governance Meeting
      • Corporate sponsored nominee service
      • Our ADR programme
      • Asset reunification - Georgeson
      • Share scam alert
      • Privacy notice for ordinary shareholders
      • FAQs
    • Corporate actions
      • Corporate actions
      • Consumer Healthcare Demerger
      • Consumer Healthcare Joint Venture
      • Agreement to acquire TESARO
    • Debt investors
    • Investor contacts
  • Media
    • Media
    • Press releases
    • Media contacts
    • Media statements
    • Media library
    • Our social media
    • Podcasts
    • RSS feeds
  • Careers
    • Careers
    • Search jobs
    • Featured careers
      • Featured careers
      • A career in data
    • Life at GSK
    • Outstanding people
      • Outstanding people
      • Great place to work
      • Meet our veterans
      • Working together
      • My GSK story
      • Innovating together
    • Experienced professionals
      • Experienced professionals
      • Business operations
      • Engineering at GSK
      • Global supply chain
      • Sales and marketing
      • Research and development
        • Research and development
        • Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)
        • Genomic sciences
      • Technology
    • Early careers
      • Early careers
      • Application process
      • Apprentice programmes
      • Internships and placements
      • Graduate programme
        • Graduate programme
        • Business operations
        • Engineering
        • Manufacturing & supply
        • Commercial
        • Research & development
        • Manufacturing sciences & technology
      • Post graduate opportunities
      • Frequently asked questions
    • Veterans
    • Our global and regional hubs
    • How we hire
      • How we hire
      • Fraudulent internet recruitment activities
      • Frequently asked questions
  • Dark mode

    Switch to dark mode to head towards a more sustainable world together. More info

  • Healthcare professionals Healthcare professionals
  • Contact us Contact us
GSK Homepage
Change locationMenu

  • Global
  • Change location
  • Dark mode

    Switch to dark mode to head towards a more sustainable world together. More info

  • Healthcare professionals Healthcare professionals
  • Contact us Contact us
GSK Homepage
  • Behind the Science magazine
  • Company
  • Innovation
  • Products
  • Responsibility
  • Investors
  • Media
  • Careers
  1. Home
  2. Search

Search

Filters

Format

219 results for "antiviral"

  • PDF - 144.8KBMedia
    Press Release Tony Wood Appointed Chief Scientific Officer Designate, GSK

    Press Release Tony Wood Appointed Chief Scientific Officer Designate, GSK

    First published: 26 March 2025

  • PDF - 230.3KBMedia
    CROI EMBRACE Study Press Release

    CROI EMBRACE Study Press Release

    First published: 10 March 2025

  • PDF - 153.4KBMedia
    China NMP File Acceptance

    China NMP File Acceptance

    First published: 27 March 2026

  • PDF - 211.1KBMedia
    Press Release GSK Announces Positive Results From B Well 1 And B Well 2 Phase III Trials For Bepirovirsen, A Potential First In Class Treatment For Chronic Hepatitis B 1

    Press Release GSK Announces Positive Results From B Well 1 And B Well 2 Phase III Trials For Bepirovirsen, A Potential First In Class Treatment For Chronic Hepatitis B 1

    First published: 07 January 2026

  • PDF - 153.3KBMedia
    Bepi File Japan Final (1)

    Bepi File Japan Final (1)

    First published: 26 February 2026

  • PDF - 237.2KBMedia
    Press Release SBP Group Collaboration (1)

    Press Release SBP Group Collaboration (1)

    First published: 11 May 2026

  • PDF - 243.2KBMedia
    Bepi FDA File Acceptance SEA

    Bepi FDA File Acceptance SEA

    First published: 27 April 2026

  • PDF - 340.3KBMedia
    Bepirovirsen File Acceptance EMA SEA

    Bepirovirsen File Acceptance EMA SEA

    First published: 26 March 2026

  • PDF - 274.6KBMedia
    AASLD Press Release

    AASLD Press Release

    First published: 27 November 2024

  • PDF - 230.1KBMedia
    Press Release Viiv Healthcare Extends Voluntary Licensing Agreement With Medicines Patent Pool To Enable Access To Innovative Long Acting Injectable HIV Treatment

    Press Release Viiv Healthcare Extends Voluntary Licensing Agreement With Medicines Patent Pool To Enable Access To Innovative Long Acting Injectable HIV Treatment

    First published: 14 July 2025

  1. previous
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. 10
  12. next
Gsk Logo

This is our global website, intended for visitors seeking information on GSK's worldwide business.  Our market sites can be reached by visiting our location selector.  

 

© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

GSK plc. Registered in England and Wales No. 3888792.

Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG

> Modern Slavery Act Statement 2025 (PDF - 187.7KB)

GSK websites
  • Locations selector
  • Social media directory
  • GSKPro for healthcare professionals
  • GSK study register
  • Supplier website
  • ViiV Healthcare
Quick links
  • Behind the Science magazine
  • Company
  • Innovation
  • Products
  • Responsibility
  • Investors
  • Media
  • Careers
Get in touch
  • Contact us
  • Partnerships
  • Report a possible side effect
  • GSK Speak up
Follow us on:
  • Accessibility
  • Digital sustainability
  • Terms of use
  • Cookie policy
  • Privacy notice
  • Sitemap